121 related articles for article (PubMed ID: 8863519)
1. Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors.
Parker EM; Izzarelli DG; Lewis-Higgins L; Palmer D; Shapiro RA
J Neurochem; 1996 Nov; 67(5):2096-103. PubMed ID: 8863519
[TBL] [Abstract][Full Text] [Related]
2. A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists.
Adham N; Tamm JA; Salon JA; Vaysse PJ; Weinshank RL; Branchek TA
Neuropharmacology; 1994; 33(3-4):387-91. PubMed ID: 7984276
[TBL] [Abstract][Full Text] [Related]
3. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
Wurch T; Colpaert FC; Pauwels PJ
Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.
Lovenberg TW; Erlander MG; Baron BM; Racke M; Slone AL; Siegel BW; Craft CM; Burns JE; Danielson PE; Sutcliffe JG
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2184-8. PubMed ID: 8384716
[TBL] [Abstract][Full Text] [Related]
5. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of 5-HT1D over 5-HT1B receptors during early embryogenesis.
Bolaños-Jiménez F; Choi DS; Maroteaux L
Neuroreport; 1997 Dec; 8(17):3655-60. PubMed ID: 9427346
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterisation of the rabbit 5-HT1D alpha and 5-HT1D beta receptors.
Harwood G; Lockyer M; Giles H; Fairweather N
FEBS Lett; 1995 Dec; 377(1):73-6. PubMed ID: 8543023
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
[TBL] [Abstract][Full Text] [Related]
9. Differences in ligand binding profiles between cloned rabbit and human 5-HT1D alpha and 5-HT1D beta receptors: ketanserin and methiothepin distinguish rabbit 5-HT1D receptor subtypes.
Bard JA; Kucharewicz SA; Zgombick JM; Weinshank RL; Branchek TA; Cohen ML
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):237-44. PubMed ID: 8878052
[TBL] [Abstract][Full Text] [Related]
10. The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors.
Choi DS; Birraux G; Launay JM; Maroteaux L
FEBS Lett; 1994 Oct; 352(3):393-9. PubMed ID: 7926008
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity.
Hamblin MW; Metcalf MA; McGuffin RW; Karpells S
Biochem Biophys Res Commun; 1992 Apr; 184(2):752-9. PubMed ID: 1315531
[TBL] [Abstract][Full Text] [Related]
12. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
Zgombick JM; Schechter LE; Macchi M; Hartig PR; Branchek TA; Weinshank RL
Mol Pharmacol; 1992 Aug; 42(2):180-5. PubMed ID: 1513320
[TBL] [Abstract][Full Text] [Related]
13. Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin.
Almaula N; Ebersole BJ; Zhang D; Weinstein H; Sealfon SC
J Biol Chem; 1996 Jun; 271(25):14672-5. PubMed ID: 8663249
[TBL] [Abstract][Full Text] [Related]
14. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain.
Barone P; Jordan D; Atger F; Kopp N; Fillion G
Brain Res; 1994 Feb; 638(1-2):85-94. PubMed ID: 8199879
[TBL] [Abstract][Full Text] [Related]
15. Conversion of the human 5-HT1D beta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis.
Metcalf MA; McGuffin RW; Hamblin MW
Biochem Pharmacol; 1992 Nov; 44(10):1917-20. PubMed ID: 1449511
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed.
Xie Z; Lee SP; O'Dowd BF; George SR
FEBS Lett; 1999 Jul; 456(1):63-7. PubMed ID: 10452531
[TBL] [Abstract][Full Text] [Related]
17. Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
Veldman SA; Bienkowski MJ
Mol Pharmacol; 1992 Sep; 42(3):439-44. PubMed ID: 1328844
[TBL] [Abstract][Full Text] [Related]
18. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
Adham N; Romanienko P; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1992 Jan; 41(1):1-7. PubMed ID: 1732716
[TBL] [Abstract][Full Text] [Related]
19. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
Choudhary MS; Craigo S; Roth BL
Mol Pharmacol; 1992 Oct; 42(4):627-33. PubMed ID: 1435740
[TBL] [Abstract][Full Text] [Related]
20. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
